Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Fegan

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Blood|August 15, 2002
Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recoverySuparno Chakrabarti, Vivien Mautner, Husam Osman, et al.
Bone Marrow Transplantation|July 27, 2004
A randomised study comparing peripheral blood progenitor mobilisation using intermediate-dose cyclophosphamide plus lenograstim with lenograstim aloneM Karanth, S Chakrabarti, R A Lovell, et al.
Blood|September 25, 2003
The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemiaMark A Cook, Donald W Milligan, Christopher D Fegan, et al.
British Journal of Haematology|May 12, 1998
Trisomy 12 is seen within a specific subtype of B-cell chronic lymphoproliferative disease affecting the peripheral blood/bone marrow and co-segregates with elevated expression of CD11aL Su'ut, S J O'Connor, S J Richards, et al.
Blood|July 19, 2003
Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantationSuparno Chakrabarti, Donald W Milligan, Deenan Pillay, et al.
British Journal of Haematology|November 23, 2006
Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemiaRebecca L Auer, Guillaume Dighiero, Lynn R Goldin, et al.
Blood|May 1, 2004
Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responsesDonald W Milligan, Savio Fernandes, Ranjit Dasgupta, et al.
Haematologica|May 9, 2020
Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-κB activity and synergise with bortezomib and ibrutinib in hematological cancersThomas Lewis, David B Corcoran, David E Thurston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumabIrit Avivi, Suparno Chakrabarti, Donald W Milligan, et al.
British Journal of Haematology|December 11, 2002
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortalitySuparno Chakrabarti, Irit Avivi, Stephen Mackinnon, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Blood|August 15, 2002
Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recoverySuparno Chakrabarti, Vivien Mautner, Husam Osman, et al.
Bone Marrow Transplantation|July 27, 2004
A randomised study comparing peripheral blood progenitor mobilisation using intermediate-dose cyclophosphamide plus lenograstim with lenograstim aloneM Karanth, S Chakrabarti, R A Lovell, et al.
Blood|September 25, 2003
The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemiaMark A Cook, Donald W Milligan, Christopher D Fegan, et al.
British Journal of Haematology|May 12, 1998
Trisomy 12 is seen within a specific subtype of B-cell chronic lymphoproliferative disease affecting the peripheral blood/bone marrow and co-segregates with elevated expression of CD11aL Su'ut, S J O'Connor, S J Richards, et al.
Blood|July 19, 2003
Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantationSuparno Chakrabarti, Donald W Milligan, Deenan Pillay, et al.
British Journal of Haematology|November 23, 2006
Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemiaRebecca L Auer, Guillaume Dighiero, Lynn R Goldin, et al.
Blood|May 1, 2004
Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responsesDonald W Milligan, Savio Fernandes, Ranjit Dasgupta, et al.
Haematologica|May 9, 2020
Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-κB activity and synergise with bortezomib and ibrutinib in hematological cancersThomas Lewis, David B Corcoran, David E Thurston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumabIrit Avivi, Suparno Chakrabarti, Donald W Milligan, et al.
British Journal of Haematology|December 11, 2002
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortalitySuparno Chakrabarti, Irit Avivi, Stephen Mackinnon, et al.
Pageof 7